Document Detail


The viability of DNA vaccines--marcus evans conference. 3-5 February 2004, London, UK.
MedLine Citation:
PMID:  15017462     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This DNA vaccines conference was aimed at examining the viability of DNA vaccines as a credible prophylactic/therapeutic technology rather than simply as an effective research tool. Presentations and panel discussion sessions focused on many of the issues facing the sector, including efficacy, manufacturing costs and public acceptability of the technology. Clinical trial data were presented for DNA vaccines in development for both human and veterinary use, including cancer, HIV infection and malaria. Presentations also covered delivery technologies (microparticles, electroporation and epidermal 'tattooing'), and the manufacturing industry reported on the latest production advances. Issues concerning human vaccine development are covered in this review.
Authors:
John B March
Publication Detail:
Type:  Congresses    
Journal Detail:
Title:  IDrugs : the investigational drugs journal     Volume:  7     ISSN:  1369-7056     ISO Abbreviation:  IDrugs     Publication Date:  2004 Mar 
Date Detail:
Created Date:  2004-03-12     Completed Date:  2004-07-06     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  100883655     Medline TA:  IDrugs     Country:  England    
Other Details:
Languages:  eng     Pagination:  226-8     Citation Subset:  IM    
Affiliation:
Moredun Research Institute, Department of Bacteriology, Penicuik, Edinburgh, EH26 0PZ, UK. John.March@mri.sari.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Drug Delivery Systems / methods*
HIV Infections / drug therapy,  genetics
Humans
Malaria / drug therapy,  genetics
Neoplasms / drug therapy,  genetics
Vaccines, DNA / administration & dosage*,  genetics
Chemical
Reg. No./Substance:
0/Vaccines, DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Signal Transduction Pathways as Therapeutic Targets. 25-28 January 2004, Luxembourg.
Next Document:  Longitudinal changes in plasma glucose values of the 75-g glucose tolerance test in triplet pregnanc...